SãoPauloMedicalJournal—RevistaPaulistadeMedicina
SaoPauloMedJ.2004;122(6):231-2.
Newtrendsforanemiaat
thebeginningofanewcentury…
IsabelaM.BenseñorE
ditorial
In a recent article published in the Archives of Internal Medicine,1theauthorscommentthat“fortoolong,anemia
hasbeenviewedasaninnocentbystander”initsfrequentas-sociationwithchronicdiseases.Howcanweinterpretanemia inBrazil,atthismoment?
First,long-termtimetrendsinBrazil,basedonthreecross-sectionalstudiesconductedinthe1970s,80s,and90s,showusa rapiddeclineintheprevalenceofchildhoodmalnutritionanda rapidincreaseinadultoverweight/obesity,butahighprevalence ofanemiawithapossibleepidemictrendamongchildrenaged underfive.2Recentdatasuggestthattheprevalenceofanemia
isincreasinginallregionsinthecountry,includingricherand poorer areas, with the same burden. One possible cause for this,amongchildrenagedundertwo,isthoughttobethelarge increaseinmilkconsumption.3Recentdataontheprevalenceof
anemiaamongadultsaremoresparse:therearejusttwostudies, fromPernambucoandPiauí,whichsimultaneouslyevaluated children and adults and found a nearly 25% prevalence of anemiaamongadults.4
Second,thediagnosisofanemiaofmoderateseverity(9-13g/dl) isverycomplicatedbecauseofourlowperceptionofmildpallor atphysicalexamination.Severaldatafromtheliteratureconfirm thispoint.5-7InBrazil,thereliabilityandvalidityofthepresence
ofpalmarandconjunctivalpallorforanemiadetectionpurposes havebeenevaluatedbySpinellietal.8Theresultsfromcomparing
anemiadiagnosesmadebypalmarandconjunctivalexamination withhemoglobinlevelsdeterminedbybloodcellcountshowedlow levelsofagreement.Conjunctivalpallorwasmoresensitivethan palmarpallorfordiagnosinganemia.Theauthorsconcludedthat itwasstilltooearlytorecommendroutineuseofthistechnique withoutanykindofconfirmation.Becauseofthisdifficultyin evaluatinganemiainaclinicalexamination,severalpapershave discussedsimplemethodsfordiagnosinganemiainAfricancoun-trieswherebloodcounttestsareanimpossibility.Newstrategies havebeenproposed,includinghemoglobincolorscalesonwhicha dropofbloodiscomparedbymeansofaplasticscaleofredcircles withthehemoglobinlevelsthattheserepresent.6,9
Recentdatahaveshownthatquantifyinganemiabychoos-ing between four levels is a very imprecise method with no interobserverreliability.Itismorecorrecttoclassifythegrade ofpallorasslight,moderateorsevereor,better,aspresenceor absenceofpallor.10Suchdifficultywillbeprobablymoreintense
forhemoglobinlevelsof9-13g/dl.
RecentdatafromHospitaldasClínicas,FaculdadedeMe-dicinadaUniversidadedeSãoPaulo,haveshownthat,outof 95patientsevaluatedatanoutpatientclinic,fourdiagnosesof anemiaweremadebyphysicalexamination.Ofthese95patients, andinadditiontothefourpatientswithanemia,another31 patientsweresubmittedtoacompletebloodcountforvarious reasonsotherthananemia.Ofthe35completebloodcounts,11 showedanemia(thefourdiagnosedbyphysicalexaminationand anothersevenforwhomnopallorwasobservedduringphysical examination):onecaseofmegaloblasticanemia,fivecasesofiron deficiencyanemiaandfivecasesofanemiaassociatedwithchronic disorders.Allthesepatientshadhemoglobinlevelsbetween9and 13g/dl(Benseñoretal.;unpublisheddata).
Thetreatmentofmegaloblasticandirondeficiencyanemia is very simple. However, for megaloblastic anemia, it needs tobedeterminedwhethertheanemiaiscausedbyalackof folateorvitaminB12.Forirondeficiencyanemia,itneedsto bedeterminedwhetherbloodlossispresent,andonepossible causeofthisiscoloncancer,whichisfrequentlymanifestedby irondeficiencyanemia.
And what about anemia that is associated with chronic disorders?The diagnoses are made but treatment is lacking. Whatistheproblemhere?
Theproblemisthatthereisnowalotofevidencesuggest-ingthatwecannotmerelyconsideranemiatobeaninnocent bystander. Recent data has shown that anemia can interfere intheprognosisforchronicdiseasessuchasheartfailureand cancer,inthemorbiditycausedbytheseandotherdiseasesand inthequalityoflifeassociatedwiththesedisorders.Mozaffarian etal.11showedinaprospective,randomizedstudythatanemia
isapredictorformortalityincasesofsevereheartfailure.Ina retrospectivestudyofpatientsundergoinghemodialysis,hemo-globinlevelsoflessthan8g/dlwereassociatedwithatwofold increaseintheprobabilityofdeath,comparedwithpatients withhemoglobinlevelsofmorethan10g/dl.12Anobservational
studyhasnotedanassociationbetweenhemoglobinlevelsof lessthan10g/dlandincreasedmortalityratesamongpatients withcardiovasculardisorders,thussuggestinglowtoleranceof anemiaamongsuchpatients.13
SãoPauloMedicalJournal—RevistaPaulistadeMedicina
with heart failure, anemia treatment can improve symptoms and decrease the number of hospital days.16 Several trials are
nowtestingthebenefitsofcorrectinganemiainpatientswith varioustypesofcancer,basedonthefactthatforcertaintypes ofcancer,thepresenceofanemiacanbeassociatedwithworse localandregionalcontrolandsurvivalrates.17,18
Anemiacanalsohaveanimpactonqualityoflife,asconfirmed inseveralstudiesinwhichaquestionnairewasappliedtomeasure qualityoflifebeforeanemiatreatmentandsomemonthsafter treatment.Mostofthesestudieshaveshownanimprovementin qualityoflife,withhemoglobinlevelsof8-14g/dl.19,20
Thus,whenweevaluateapatientinanoutpatientclinic,it
isnowimportanttobesensitivetowardsmildcasesofanemia. Perhapswehavetobelessrestrictiveregardingcompleteblood cellcountspreciselybecausewearenotgoodenoughatlooking formildpallor.Thisgoesagainstwhatwelearnedatschoolbut isperhapsmoreappropriateforborderlinelevelsofanemiain thisnewcentury,withitsnewperceptionofqualityoflife.The otherpointisthatourdutyisnotjusttodiagnoseanemia,but alsotoinvestigateitspossiblecausesandthentotreatthem.
IsabelaM.Benseñor.AssistantprofessorintheDivisionofClinical Medicine,HospitaldasClínicas,UniversidadedeSãoPaulo,São Paulo,Brazil.E-mail:isabensenor@hcnet.usp.br
1. NissensonAR,GoodnoughLT,DuboisRW.Anemia:notjustaninnocentbystander? ArchInternMed.2003;163(12):1400-4.
2. Batista Filho M, Rissin A. A transição nutricional no Brasil: tendências regionais e temporais.[NutritionaltransitioninBrazil:geographicandtemporaltrends].CadSaúde Pública.2003;19(Suppl1):S181-S191.
3. Levy-CostaRB.ConsumodeleitedevacaeanemianainfâncianomunicípiodeSãoPaulo [dissertation].SãoPaulo:FaculdadedeSaúdePúblicadaUniversidadedeSãoPaulo;2002. 4. Santos LMP. Bibliografia sobre deficiência de micronutrientes no Brasil, 1990-2000:
Anemia.Brasília:OrganizaçãoPan-AmericanadaSaúde/OrganizaçãoMundialdaSaúde; 2002.AvailablefromURL:http://www.opas.org.br/sistema/arquivos/pes_vol2a.pdf.Ac-cessedin2004(Aug17).
5. ShethTN,ChoudhryNK,BowesM,DetskyAS.Therelationofconjunctivalpallorto thepresenceofanemia.JGenInternMed.1997;12(2):102-6.
6. KalterHD,BurnhamG,KolstadPR,etal.Evaluationofclinicalsignstodiagnoseanaemia inUgandaandBangladesh,inareaswithandwithoutmalaria.BullWorldHealthOrgan. 1997;75(Suppl1):103-11.
7. Sanchez-CarrilloCI.Biasduetoconjunctivahueandtheclinicalassessmentofanemia. JClinEpidemiol.1989;42(8):751-4.
8. SpinelliMGN,SouzaJMP,SouzaSB,SesokoEH.Confiabilidadeevalidadedapalidez palmaredeconjuntivascomotriagemdeanemia.[Reliabilityandvalidityofpalmarand conjunctivalpallorforanemiadetectionpurposes].RevSaúdePública.2003;37(4):404-8. 9. LewisSM,StottGJ,WynnKJ.Aninexpensiveandreliablenewhaemoglobincolourscale
forassessinganaemia.JClinPathol.1998;51(1):21-4.
10. DragerLF,AbeJM,MartinsMA,LotufoPA,BensenorIJ.Impactofclinicalexperienceon quantificationofclinicalsignsatphysicalexamination.JInternMed.2003;254(3):257-63. 11. MozaffarianD,NyeR,LevyWC.Anemiapredictsmortalityinsevereheartfailure:the
prospectiverandomizedamlodipinesurvivalevaluation(PRAISE).JAmCollCardiol.
2003;41(11):1933-9.
12. CollinsAJ,LiS,StPeterW,etal.Death,hospitalization,andeconomicassociationsamong incidenthemodialysispatientswithhematocritvaluesof36to39%.JAmSocNephrol. 2001;12(11):2465-73.
13. CarsonJL,DuffA,PosesRM,etal.Effectofanaemiaandcardiovasculardiseaseonsurgical mortalityandmorbidity.Lancet.1996;348(9034):1055-60.
14. BesarabA,BoltonWK,BrowneJK,etal.Theeffectsofnormalascomparedwithlow hematocritvaluesinpatientswithcardiacdiseasewhoarereceivinghemodialysisand epoetin.NEnglJMed.1998;339(9):584-90.
15. LevinA,ThompsonCR,EthierJ,etal.Leftventricularmassindexincreaseinearlyrenal disease:impactofdeclineinhemoglobin.AmJKidneyDis.1999;34(1):125-34. 16. PickettJL,ThebergeDC,BrownWS,SchweitzerSU,NissensonAR.Normalizinghematocrit
indialysispatientsimprovesbrainfunction.AmJKidneyDis.1999;33(6):1122-30. 17. SilverbergDS,WexlerD,ShepsD,etal.Theeffectofcorrectionofmildanemiainsevere,
resistantcongestiveheartfailureusingsubcutaneouserythropoietinandintravenousiron: arandomizedcontrolledstudy.JAmCollCardiol.2001;37(7):1775-80.
18. Fein DA, LeeWR, Hanlon AL, et al. Pretreatment hemoglobin level influences local control and survival ofT1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol.1995;13(8):2077-83.
19. GlaspyJ,BukowskiR,SteinbergD,TaylorC,TchekmedyianS,Vadhan-RajS.Impactof therapywithepoetinalfaonclinicaloutcomesinpatientswithnonmyeloidmalignancies duringcancerchemotherapyincommunityoncologypractice.ProcritStudyGroup.J ClinOncol.1997;15(3):1218-34.
20. DemetriGD,KrisM,WadeJ,DegosL,CellaD.Quality-of-lifebenefitinchemotherapy patientstreatedwithepoetinalfaisindependentofdiseaseresponseortumortype:results from a prospective community oncology study. Procrit Study Group. J Clin Oncol. 1998;16(10):3412-25.
REFERENCES